Medindia

X

NIH Awards Emory $3.6 Million for Schizophrenia Gene Research

by Medindia Content Team on  May 15, 2007 at 1:36 AM Mental Health News   - G J E 4
NIH Awards Emory $3.6 Million for Schizophrenia Gene Research
The National Institute of Mental Health of the National Institutes of Health has awarded Emory University School of Medicine a $3.6 million research grant to test schizophrenic patients for a recently discovered variation in the human genome. The project is led by Stephen T. Warren, PhD, Timmie Professor and chair of the Department of Human Genetics.
Advertisement

Schizophrenia is a severe and common psychiatric disorder that has a strong genetic predisposition. Despite the knowledge that genetic changes can lead to the disorder, however, few genes have been identified.

Advertisement
Recently, scientists have discovered an entirely new and previously unknown form of variation in the human genome, called "copy number variation," or CNV. This variation includes deletions and duplications of segments of DNA previously unrecognized in the general population.

Scientists now believe every individual may carry as many as 100 CNVs. While these variations generally do not cause disease on their own, says Dr. Warren, in combination with other genetic changes and/or environmental factors they may well contribute to one's overall risk of disease.

Using cutting-edge technology available to only a few major research centers, the Emory project will screen a collection of 500 schizophrenic patients and 500 controls (individuals without schizophrenia) for CNV throughout the entire human genome.

The new technology uses "DNA chips," manufactured by NimbleGen Systems, Inc., that can compare DNA copy number differences in a reference genome to the genomes of the individuals being screened. Scientists can array 2.1 million locations in the genome, or about one in every 1,000 base pairs, on a single chip the size of a microscope slide. The project team will use the new Emory high performance computer cluster to analyze the data.

"By helping us identify CNVs, we believe this new kind of chip technology may lead us to the specific genes that influence schizophrenia and other major psychiatric diseases," Dr. Warren says.

The schizophrenia project is the first involvement in a disorder other than fragile X syndrome in over a decade for Dr. Warren, who is well know for his discoveries regarding this frequent form of mental retardation.

The Emory scientists are collaborating with Ann E. Pulver, ScD, professor of psychiatry and behavioral sciences at Johns Hopkins University, who collected the samples to be tested.

Source: Emory WHSC
LIN/B
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
my daughter suffers from scizo for the last 6 yrs01 october 10th in usa brought to india.she improves and again relpses.every time she gets a relapse the recovery time is becoming longer presently she started abusing with un parliamentar language . sheis on ,ciplar ativan-10mg ,quitepine,amezeo forlast18 days she sleeps day6 hrs and whole night now no abuses but reduced auditory hallucinnations she is on continuos medical supervision forthethe last 4yrs still not organised,no initiation except to eat. pl. advise regards samanta
guest Monday, July 30, 2007
Hypofunction of glutamatergic neurons has been hypothesized to caused schizophrenia. For example, see conclusions from the symposium entitled, "Not Just Dopamine Any More: Emerging Glutamatergic Therapies for Schizophrenia," (Toronto, 2006) http://www.medscape.com/viewarticle/537385 Calcium deficiency may be a predisposing or causative factor in schizophrenia ? This concept is based on the demonstration that „NMDA receptor hypofunction“ can be based on calcium-deficiency, potentiated by nutritional hypoproteinemia - see website www.bse-expert.cz ; chapter “Hyperfunction (Alzheimer’s disease and Parkinson disease) and hypofunction (schizophrenia) of glutamatergic neurons”.
hlasny Friday, June 8, 2007

You May Also Like

Advertisement
View All